Authors: Fleming, DR Wolff, SN Fay, JW Brown, RA Lynch, JP Bolwell, BJ Stevens, DA Goodman, SA Greer, JP Stein, RS Pineiro, LA Collins, RH Goldsmith, LJ Herzig, GP Herzig, RH

Citation: Dr. Fleming et al., Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the north American marrow transplant group, LEUK LYMPH, 35(1-2), 1999, pp. 91-98

Authors: Gale, RP Park, RE Dubois, RW Herzig, GP Hocking, WG Horowitz, MM Keating, A Kempin, S Linker, CA Schiffer, CA Wiernik, PH Weisdorf, DJ Rai, KR

Citation: Rp. Gale et al., Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase, LEUK RES, 23(9), 1999, pp. 817-826

Authors: Gale, RP Park, RE Dubois, RW Herzig, GP Hocking, WG Horowitz, MM Keating, A Kempin, S Linker, CA Schiffer, CA Wiernik, PH Weisdorf, DJ Rai, KR

Citation: Rp. Gale et al., Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission, LEUK RES, 23(8), 1999, pp. 709-718

Authors: Khatri, VP Baiocchi, RA Peng, RQ Oberkircher, AR Dolce, JM Ward, PM Herzig, GP Caligiuri, MA

Citation: Vp. Khatri et al., Endogenous CD8(+) T cell expansion during regression of monoclonal EBV-associated posttransplant lymphoproliferative disorder, J IMMUNOL, 163(1), 1999, pp. 500-506